Categories
Journal of Drugs in Dermatology

A letter from the editor-in-chief

A letter from the editor-in-chief Dermatologic surgery has never played a larger role in our field than it does today. This is reflected in the fact that there are more surgery questions on the Dermatology Board Exam each year. Having been involved in dermatologic surgery from its inception, I am particularly gratified to see the […]

Categories
Journal of Drugs in Dermatology

The effects of topical arnica in the resolution of laser-induced bruising – Washington Whispers

The effects of topical arnica in the resolution of laser-induced bruising – Washington Whispers – Brief Article This is a randomized, placebo-controlled trial evaluating the effects of topical arnica in the resolution of laser-induced bruising. Nineteen patients with facial telangiectasias were enrolled in the study and were divided into pretreatment and post-treatment groups. The pretreatment […]

Categories
Journal of Drugs in Dermatology

The medical uses and side effects of etanercept with a focus on cutaneous disease

The medical uses and side effects of etanercept with a focus on cutaneous disease Noah Scheinfeld Abstract Etanercept is a dimeric fusion protein that has been approved for the treatment of rheumatoid arthritis, juvenile rheumatoid arthritis, psoriatic arthritis, active ankylosing spondylitis and moderate to severe plaque psoriasis. It has been reported to be useful in […]

Categories
Journal of Drugs in Dermatology

Peripheral stem cell transplantation plus monoclonal antibody therapy in treating patients with high-risk hematologic cancer, refractory breast or kidney cancer, or melanoma

Peripheral stem cell transplantation plus monoclonal antibody therapy in treating patients with high-risk hematologic cancer, refractory breast or kidney cancer, or melanoma This study is currently recruiting patients. Sponsored by Duke Comprehensive Cancer Center National Cancer Institute (NCI) Peripheral stem cell transplantation replaces immune cells that were destroyed by chemotherapy which was used to kill […]

Categories
Journal of Drugs in Dermatology

Study to compare the efficacy and safety of CC-5013 vs. placebo in subjects with metastatic malignant melanoma

Study to compare the efficacy and safety of CC-5013 vs. placebo in subjects with metastatic malignant melanoma – Clinical Trial Review Sponsored by: Celgene Corporation, ICON Clinical Research Purpose: Subjects are randomized to one of two treatment arms. All subjects are screened for eligibility within 28 days prior to randomization. The study consists of a […]

Categories
Journal of Drugs in Dermatology

Combination calcipotriol/betamethasone shows more rapid onset of action than monotherapy in the treatment of psoriasis – Washington Whispers

Combination calcipotriol/betamethasone shows more rapid onset of action than monotherapy in the treatment of psoriasis – Washington Whispers – Author Abstract This double-blind, randomized study compares the effectiveness of betamethasone dipropionate ointment and calcipotriol ointment alone as compared to the use of a combination ointment. 1,106 patients were randomozed to twice-daily treatments with either the […]

Categories
Journal of Drugs in Dermatology

Current concepts in the management of actinic keratosis

Current concepts in the management of actinic keratosis THIS SUPPLEMENT TO THE JOURNAL OF DRUGS IN DERMATOLOGY, SPONSORED BY DERMIK LABORATORIES, IS ADAPTED FROM A RECENT ROUNDTABLE SYMPOSIUM HELD IN NEW YORK CITY FEATURING SIX RESPECTED DERMATOLOGISTS, EACH AN EXPERT ON TREATING SKIN DISORDERS. THEIR COMBINED EXPERTISE AND EXPERIENCES WITH TREATING ACTINIC KERATOSES PROVIDED THE […]

Categories
Journal of Drugs in Dermatology

safety and efficacy of long-term treatment

Dapsone gel 5% for the treatment of acne vulgaris: safety and efficacy of long-term treatment Anne W. Lucky Abstract Dapsone gel 5%, a topical formulation of dapsone, was shown to deliver clinically effective doses of dapsone with minimal systemic absorption in 2 randomized, vehicle-controlled, 12-week studies of patients with acne vulgaris. A 12-month, open-label, long-term […]

Categories
Journal of Drugs in Dermatology

Open label study of OnTAK in previously treated cutaneous T-cell lymphoma patients – denileukin diftitox

Open label study of OnTAK in previously treated cutaneous T-cell lymphoma patients – denileukin diftitox – Clinical Trial Review Sponsored by: Ligand Pharmaceuticals Purpose: The purpose of this study is to provide an opportunity for patients who exhibit progressive disease while receiving placebo on the companion 93-04-11 study to receive ONTAK. It is also designed […]

Categories
Journal of Drugs in Dermatology

Venous thrombosis occurring after initiation of thalidomide for the treatment of cicatricial pemphigoid

Venous thrombosis occurring after initiation of thalidomide for the treatment of cicatricial pemphigoid – Case Reports Eric Howell Abstract Thalidomide is increasingly being used for the treatment of a variety of dermatologic conditions. Some of the risks associated with thalidomide use, however, are still being uncovered. Increased incidence of venous thrombosis following thalidomide use has […]